MOBI (Mobia Medical) ROA %: -132.40% (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MOBI Mobia Medical Inc MOBI
7 GF Score
Price $11.17
! 1 Warning Sign
View Full Analysis

What is Mobia Medical ROA %?

Mobia Medical MOBI -2.02% 7 ROA % is -132.40% as of Dec. 2025. GuruFocus rates MOBI with a GF Score™ of 7/100. The stock has 1 warning sign investors should review. Among 857 Medical Devices & Instruments companies, Mobia Medical ranks worse than 94.4% on this metric.

ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. Mobia Medical's annualized Net Income for the quarter that ended in Dec. 2025 was $-46.50 Mil. Mobia Medical's average Total Assets over the quarter that ended in Dec. 2025 was $35.12 Mil. Therefore, Mobia Medical's annualized ROA % for the quarter that ended in Dec. 2025 was -132.40%.

The historical rank and industry rank for Mobia Medical's ROA % or its related term are showing as below:

MOBI' s ROA % Range Over the Past 10 Years
Min: -132.4   Med: -121.89   Max: -111.37
Current: -132.4

During the past 2 years, Mobia Medical's highest ROA % was -111.37%. The lowest was -132.40%. And the median was -121.89%.

MOBI's ROA % is ranked worse than
94.4% of 857 companies
in the Medical Devices & Instruments industry
Industry Median: 0.55 vs MOBI: -132.40

Mobia Medical  (NAS:MOBI) ROA % Explanation

ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A bank’s ROA % is typically well under 2%.

Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:

ROA %(Q: Dec. 2025 )
=Net Income/Total Assets
=-46.498/35.12
=(Net Income / Revenue)*(Revenue / Total Assets)
=(-46.498 / 32.041)*(32.041 / 35.12)
=Net Margin %*Asset Turnover
=-145.12 %*0.9123
=-132.40 %

Note: The Net Income data used here is one times the annual (Dec. 2025) net income data. The Revenue data used here is one times the annual (Dec. 2025) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.

E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.


Mobia Medical ROA % Related Terms


Mobia Medical ROA % Historical Data

* Premium members only.

The historical data trend for Mobia Medical's ROA % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Mobia Medical ROA % Chart

Mobia Medical Annual Data
Trend Dec24 Dec25
ROA %
-111.37 -132.40

Mobia Medical Semi-Annual Data
Dec24 Dec25
ROA % -111.37 -132.40

MOBI vs SI, PACB, KIDS: ROA % Comparison

For the Medical Devices subindustry, Mobia Medical's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mobia Medical ROA % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Mobia Medical's ROA % distribution charts can be found below:

* The bar in red indicates where Mobia Medical's ROA % falls into.


MOBI
7GF Score
Mobia Medical Inc MOBI
ROA % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Mobia Medical ROA % Calculation

Mobia Medical's annualized ROA % for the fiscal year that ended in Dec. 2025 is calculated as:

ROA %=Net Income (A: Dec. 2025 )/( (Total Assets (A: Dec. 2024 )+Total Assets (A: Dec. 2025 ))/ count )
=-46.498/( (22.091+48.149)/ 2 )
=-46.498/35.12
=-132.40 %

Mobia Medical's annualized ROA % for the quarter that ended in Dec. 2025 is calculated as:

ROA %=Net Income (Q: Dec. 2025 )/( (Total Assets (Q: Dec. 2024 )+Total Assets (Q: Dec. 2025 ))/ count )
=-46.498/( (22.091+48.149)/ 2 )
=-46.498/35.12
=-132.40 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is one times the annual (Dec. 2025) net income data. ROA % is displayed in the 30-year financial page.

Frequently Asked Questions Learn more about ROA % →
What does a ROA % of -132.40% mean?
Mobia Medical (MOBI) has a ROA % of -132.40% as of Dec. 2025. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Mobia Medical and its competitors. According to the industry distribution chart, Mobia Medical ranks #809 out of 857 companies in the Medical Devices & Instruments industry, placing it in the top 94.4%.
Is Mobia Medical's ROA % too high?
Mobia Medical's current ROA % is -132.40%. Based on the distribution chart, Mobia Medical ranks #809 out of 857 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Mobia Medical has a GF Score™ of 7/100, reflecting its overall financial health beyond just this single metric.
How does Mobia Medical's ROA % compare to SI and PACB?
According to the Medical Devices & Instruments industry distribution chart, Mobia Medical ranks #809 out of 857 companies for ROA %. This places Mobia Medical in the lower half of its industry. The industry median ROA % is 0.55. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROA % for a Medical Devices & Instruments company?
The median ROA % among Medical Devices & Instruments companies is 0.55, based on 857 companies in the industry. Companies in the top quartile (top 25%) have a ROA % significantly above this median, while those in the bottom quartile fall well below. However, ROA % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROA % mean?
A high ROA % can signal that a stock is expensive relative to its fundamentals. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Mobia Medical and its competitors. For the Medical Devices & Instruments industry, the median ROA % is 0.55 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Mobia Medical's current ROA % is -132.40%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mobia Medical stock overvalued right now?
Mobia Medical (MOBI) has a current ROA % of -132.40%. The current ROA % is -132.40%. Mobia Medical's overall GF Score™ is 7/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROA % calculated?
ROA % is calculated from a company's financial statements. For Mobia Medical (MOBI), the current ROA % is -132.40% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Mobia Medical Business Description

Address 2802 Flintrock Trace, Suite 226, Austin, TX, USA, 78738
Mobia Medical Inc is a commercial-stage medical device company redefining stroke recovery for survivors living with life-altering motor impairments. The company develops, markets and sells devices for the treatment of medical conditions. Its flagship device is the Vivistim Paired Vagus Nerve Stimulation system, which is used to support motor function rehabilitation in patients with chronic ischemic stroke. The company generates all of its revenue from the sale of the Vivistim System to customers, mainly primary and comprehensive stroke centers, in the United States.
7GF Score

Get the complete analysis for MOBI

ROA % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$11.17
Price